How much does Daklinza cost?
Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on March 1, 2021.
Official Answer
by Drugs.comWhen Daklinza (daclatasvir) was on the market, the wholesale cost for a 12-week course was roughly $63,000, but patients paid a range of $72,000 to $75,000. Daklinza and the generic daclatasvir was discontinued by Bristol Myers Squibb in 2019 due to business reasons.
Daklinza (daclatasvir) was formerly approved for the treatment of chronic hepatitis C virus (HCV) in adults, in combination with sofosbuvir (brand name: Sovaldi), with or without ribavirin, in genotypes 1 and 3, including hard to treat HCV patients such as those with HIV-1 co-infection, advanced cirrhosis, or post-liver transplant recurrence of HCV.
Daklinza is classified as a HCV NS5A inhibitor.
References
- Important information about the discontinuation of Daklinza. Bristol Myers Squibb. Accessed March 1, 2021 at https://www.bms.com/patient-and-caregivers/our-medicines/discontinuation-of-daklinza.html
Related Medical Questions
- What are the new drugs for the treatment of hepatitis C?
- Does Mavyret cure hep C (HCV)? What is the success rate?
- Does Epclusa cure Hep C, what is the success rate?
- How much does Epclusa cost?
- Can you take antibiotics with Mavyret?
- How does Epclusa work in the body?
- What is the difference between Vosevi and Epclusa?
- Does Sovaldi cure hepatitis C?
- What's the difference between Viekira Pak and Viekira XR?
- What types of Hepatitis C does Mavyret treat?
- What type of Hepatitis C is Zepatier used to treat?
- What types of hepatitis C (HCV) does Vosevi treat?
Drug Information
Related Support Groups
- Daclatasvir (2 questions, 4 members)
- Daklinza (2 questions, 9 members)
- Hepatitis C (36 questions, 668 members)